Patents
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
05/2007
05/31/2007WO2006134144A3 Process of producing bleach boosters
05/31/2007CA2630860A1 Urea derivatives useful as calcium receptor modulators
05/30/2007EP1603923B1 Metal complexes
05/30/2007EP0914605B1 Molecular model for vla-4 inhibitors
05/30/2007CN1972913A Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity
05/29/2007US7223765 3-[4-(3,4-Dichlorophenyl)piperazin-1-yl]-1-(2,3-dihydro-1H-indol-1-yl)propan-1-one or salts for example; psychological disorders such as schizophrenia, generalised anxiety disorder, panic disorder, and obsessive compulsive disorder; high affinity for dopamine D4 receptors
05/24/2007WO2007058583A2 Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies
05/24/2007US20070117797 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
05/24/2007CA2629831A1 Novel 2-amino-heterocycles useful in the treatment of abeta-related pathologies
05/23/2007EP1786778A1 Novel substituted heteroaryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors
05/23/2007EP1786768A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions
05/23/2007EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
05/23/2007CN1968930A Bicyclic, nitrogen-containing heterocycles aromatase inhibitors
05/23/2007CN1968929A Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments
05/22/2007US7220880 For therapy of diabetes mellitus, cardiovascular disease, obesity, Syndrome X and gastrointestinal disease, such as, inflammatory bowel disease
05/22/2007US7220781 Meta-benzamidine derivatives as serine protease inhibitors
05/22/2007US7220759 Isoquinoline compound and pharmaceutical use thereof
05/22/2007CA2219692C S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
05/18/2007WO2007002313A3 Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants
05/16/2007EP1784394A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
05/16/2007EP1784390A2 Substituted benzofused heterocycles
05/16/2007EP1306373B1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
05/16/2007CN1964976A Extraction of alkaloids from opium
05/16/2007CN1964957A Anionic-sweetener-based ionic liquids and methods of use thereof
05/16/2007CN1315806C Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
05/15/2007US7217740 Diarylsulfones as 5-HT2A antagonists
05/15/2007US7217728 For therapy of reperfusion injury
05/15/2007US7217714 1-(3-carboxamido-3-phenylpropyl)piperidin-4-yl -triazole or oxazole derivatives, for treatment and prevention of infection by HIV-1 and genetically related retroviruses
05/10/2007WO2007025709A3 Organic compounds
05/10/2007WO2006120525A3 Processes for the preparation of nelfinavir and new crystalline form of nelfinavir mesylate
05/10/2007US20070105838 Bicyclic Benzamide Compoundssa as Histamine H3 Receptor Ligand Useful in the Treatment of Neurological Diseases
05/10/2007US20070105834 histamine H3 receptor modulators; obesity, diabetes and central nervous system diseases such as vigilance and sleep disorders; e.g. (+)-2-(cyclohexylmethyl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl] -1,2,3 ,4-tetrahydroisoquinoline-7-sulfonamide
05/10/2007DE60119336T2 Verwendungen von thaliporphin oder seinen derivaten in der behandlung von herzkrankheiten und seine herstellung Uses of thaliporphine or its derivatives in the treatment of heart diseases and its production
05/09/2007CN1960991A Tetrahydro-imidazo [1,5-A] pyridin derivatives as aldosterone synthase inhibitors
05/09/2007CN1960975A Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP)
05/09/2007CN1960727A Naphthalene derivatives useful as histamine-3-receptor ligands
05/09/2007CN1958568A A kind of compound for preventing or curing infection of helicobacter pylori, preparation method, and application
05/08/2007US7214714 for treatment of renal diseases, cerebrovascular diseases and circulatory diseases
05/08/2007US7214689 Isoquinoline compounds
05/08/2007CA2276098C Tricyclic benzo[e]isoindoles and benzo[h]isoquinolines
05/03/2007WO2007050124A1 Fused piperidine derivatives and their uses as therapeutic agents
05/03/2007WO2007048788A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases
05/03/2007CA2623879A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases
05/02/2007EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands
05/02/2007EP1778642A1 5-ht7 receptor antagonosts
05/02/2007EP1778641A1 5-ht7 receptor antagonists
05/02/2007EP1778640A1 Trifluoromethyl substituted benzamides as kinase inhibitors
05/02/2007EP1778639A2 Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
05/02/2007EP1778206A2 Small molecule inhibitors of anti-apoptotic bcl-2 family members and the uses thereof
05/02/2007EP1458707B1 New Indol-2-one derivatives
05/02/2007EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
05/02/2007CN1956962A Tetrahydroisoquinoline sulfonamide derivatives, the preparation method thereof, and the use of the same in therapeutics
05/02/2007CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/01/2007US7211586 Substituted tetrahydroisoquinolines
05/01/2007US7211585 N-[3-(3,4-Dihydro-1H-isoquinolin-2-yl)-propyl]-2-methyl-5-nitro-benzenesulfonamidehydrochloride; selective ligands of the 5-HT7 receptor; treating Central nervous system disorders
05/01/2007US7211584 N-[3-(3,4-Dihydro-1H-isoquinolin-2-yl)-propyl]-2-methyl-5-nitro-benzenesulfonamidehydrochloride; selective ligands of the 5-HT7 receptor; treating Central nervous system, pain, sleep disorder, shift worker syndrome, jet lag, depression, seasonal affective disorder, migraine, anxiety, psychosis
04/2007
04/26/2007WO2007047991A1 Tetrahydroisoquinoline as lxr modulators
04/26/2007WO2007046075A1 Piperazine derivatives as antimalarial agents
04/26/2007US20070093522 To treat pain, drug addiction, or tinnitus; selectively inhibit sodium or calcium ion channels and agonize or antagonize mu -opioid receptors; N-Benzyl-N-(2-dimethylamino-ethyl)-2-(S)-[3-(4-fluorophenyl)-ureido]-3-methyl-butyramide
04/26/2007CA2623213A1 Piperazine derivatives as antimalarial agents
04/25/2007EP1776119A1 Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators
04/25/2007EP1572661B1 Crystalline form of quinapril hydrochloride and process for preparing the same
04/25/2007CN1312132C 1-benzyl tetrahydro isoquinoline compound, its preparing process and use thereof
04/24/2007US7208601 May be antagonists of the intrinsic clotting pathway by binding to and inhibiting the function of factor XI or of both factors XI and IX; for example, 2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-phenyl-thiophen-2-yl)-propionic acid; anticoagulants
04/24/2007CA2075173C Compounds and methods for inhibition of hiv and related viruses
04/18/2007EP1774968A1 Benzylisoquinoline derivative- or bisbenzylisoquinoline derivative-containing psychotropic agent, analgesic and/or antiphlogistic, and health food
04/18/2007EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
04/18/2007EP1773817A1 Substituted aryl-amine derivatives and methods of use
04/18/2007EP1773774A2 Heterocyclic acetophenone potentiators of metabotropic glutamate receptors
04/18/2007EP1773773A1 Amido compounds and their use as pharmaceuticals
04/18/2007EP1773763A1 Lysine based compounds
04/18/2007CN1950085A 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
04/18/2007CN1310890C Isoquinoline derivatives
04/17/2007US7205315 Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases
04/17/2007US7205314 Compounds for the treatment of dementia related diseases
04/17/2007US7205313 Central nervous system disorders; analgesics; headaches
04/12/2007US20070082907 Peroxisome proliferator activated receptor modulators
04/11/2007EP1399444B1 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
04/11/2007CN1946696A Tetrahydropyranyl cyclopentyl 1-substituted and 1,1-disubstituted tetrahydroisoquinoline modulators of chemokine receptor activity
04/11/2007CN1309704C Anthranyl amides and their use as medicaments
04/10/2007USRE39558 For prophylaxis and therapy of obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease
04/10/2007US7202381 Compounds as opioid receptor modulators
04/10/2007US7202364 ortho-substituted with a fused (hetero)arylamino group, e.g., carboxymethyl 2-(6-chloro-5-indanylamino)phenylacetate; treatment of COX-2 dependent disorders including rheumatoid arthritis, osteoarthritis, dysmenorrhea, pain, tumors or inflammation
04/10/2007US7202257 Ureas 1-substituted with a 5 member nitrogen-containing ring in turn substituted with an oxymethylphenyl group and 3-(hetero)aryl-substituted, e.g., 1-{3-tert-butyl-1-[3-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl}-3-(naphthalen-1-yl)urea; used to modulate of the activation state of p38 kinase protein
04/10/2007US7202253 Cycloalkyl inhibitors of potassium channel function
04/10/2007CA2154477C Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte-aggregation
04/05/2007US20070078139 Phosphodiesterase 4 inhibitors
04/05/2007DE60124600T2 Zusammensetzungen und Verfahren zur Behandlung von Zuständen, die auf Östrogen ansprechen Compositions and methods for treating conditions responsive to estrogen
04/04/2007EP1770085A1 Diamine derivative, process for producing the same and fungicide containing the derivative as active ingredient
04/04/2007EP1768654A2 Selective inhibitors of human corticosteroid syntheses
04/04/2007CN1942436A Lysine based compounds
04/04/2007CN1942432A Phenylethanolamine derivatives as beta-2 agonists
04/04/2007CN1942428A CETP inhibitors
04/04/2007CN1942186A Pyrrolidine compounds
04/03/2007US7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
04/03/2007US7199244 Cyclic amine derivatives and methods of use
04/03/2007US7199133 Antitumor agenst; thrombosis; arteriosclerosis; cardiovascular disorders; antiinflammatory agents
03/2007
03/29/2007WO2007033773A1 Substituted 4-phenyltetrahydroisoquinolines, method of producing them, their use as medicament, and also medicament containing them
03/29/2007US20070072901 1-Amino-isoquinoline derivatives for the treatment of diseases associated with inappropriate alk5
03/29/2007US20070072884 agricultural and horticultural fungal infections of plants; novel N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; 2-(6-quinolinyloxy)-N-(4-methylpent-2-yn-4-yl) butyramide
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 119